Margaret G. McGlynn, Director at AMICUS THERAPEUTICS, INC. (FOLD), sold 15,000 shares at $13.29 ($200K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Scheduled sale ($200k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.29 | 7,500 | $100K | 49.8% |
| 2 | $13.40 | 7,500 | $101K | 50.2% |
| Total | $13.35 avg | 15,000 | $200K | 100% |
| Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |
| VRTX | SELL | 2022-02-01 | $2.2M | — | Filing → |